Case Reports
doi: 10.1016/j.lungcan.2007.05.014.
Epub 2007 Jun 29.
Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation
Affiliations
- PMID: 17601631
- DOI: 10.1016/j.lungcan.2007.05.014
Item in Clipboard
Case Reports
Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation
Lung Cancer.
2007 Dec.
Abstract
We report a case of small cell lung cancer (SCLC) developing after prolonged treatment (more than 2 years) for primary adenocarcinoma of the lung, and we show that both the SCLC and non-small cell lung cancer (NSCLC) tissues obtained from the same site share the same deletion in exon 19 of EGFR. This case suggests that the activating EGFR mutations may confer the pathogenesis of a subset of SCLC.
Similar articles
-
Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung.Clin Lung Cancer. 2010 Sep 1;11(5):E1-4. doi: 10.3816/CLC.2010.n.046. Clin Lung Cancer. 2010. PMID: 20837450
-
Impact of EGFR mutation analysis in non-small cell lung cancer.Lung Cancer. 2009 Mar;63(3):315-21. doi: 10.1016/j.lungcan.2008.06.021. Epub 2008 Aug 29. Lung Cancer. 2009. PMID: 18760859 Review.
-
Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.Eur J Cancer. 2009 Aug;45(12):2197-206. doi: 10.1016/j.ejca.2009.04.039. Epub 2009 Jun 1. Eur J Cancer. 2009. PMID: 19493678
-
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.Lung Cancer. 2008 Jun;60(3):401-7. doi: 10.1016/j.lungcan.2007.10.014. Epub 2007 Nov 26. Lung Cancer. 2008. PMID: 18036700
-
Searching for a magic bullet in NSCLC: the role of epidermal growth factor receptor mutations and tyrosine kinase inhibitors.Lung Cancer. 2008 Jun;60 Suppl 2:S10-8. doi: 10.1016/S0169-5002(08)70100-4. Lung Cancer. 2008. PMID: 18513579 Review.
Cited by
-
Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas.J Natl Cancer Cent. 2021 Nov 8;1(4):153-162. doi: 10.1016/j.jncc.2021.11.001. eCollection 2021 Dec. J Natl Cancer Cent. 2021. PMID: 39036802 Free PMC article.
-
Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation.J Thorac Oncol. 2014 Jun;9(6):775-83. doi: 10.1097/JTO.0000000000000170. J Thorac Oncol. 2014. PMID: 24828661 Free PMC article.
-
Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma.Oncol Lett. 2016 Nov;12(5):4009-4012. doi: 10.3892/ol.2016.5193. Epub 2016 Sep 26. Oncol Lett. 2016. PMID: 27895763 Free PMC article.
-
Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC.Front Oncol. 2016 May 4;6:112. doi: 10.3389/fonc.2016.00112. eCollection 2016. Front Oncol. 2016. PMID: 27200298 Free PMC article. Review.
-
Acquired resistance L747S mutation in an epidermal growth factor receptor-tyrosine kinase inhibitor-naïve patient: A report of three cases.Oncol Lett. 2014 Feb;7(2):357-360. doi: 10.3892/ol.2013.1705. Epub 2013 Nov 25. Oncol Lett. 2014. PMID: 24396447 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
